Research graph
References from Interpreting histologic end points after endoscopic gastric remodeling for metabolic dysfunction–associated steatohepatitis. Local targets link to admitted publications; unresolved targets remain external evidence.
Endoscopic gastric remodeling and its histologic impact on metabolic dysfunction–associated steatohepatitis: a 12-month prospective study
10.1016/j.gie.2026.02.042 · 2026 · External reference
Endoscopic gastric remodeling and its histologic impact on metabolic dysfunction–associated steatohepatitis: a 12-month prospective study
10.1016/j.gie.2026.02.042 · 2026 · External reference
The role of endoscopic therapies for patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
10.1080/17474124.2026.2632873 · 2026 · External reference
The role of endoscopic therapies for patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
10.1080/17474124.2026.2632873 · 2026 · External reference
Liver biopsy in metabolic-associated steatotic liver disease: accuracy, challenges, and alternatives
2026 · External reference
Liver biopsy in metabolic-associated steatotic liver disease: accuracy, challenges, and alternatives
2026 · External reference
Combination therapy of endoscopic gastric remodeling with GLP-1RA for the treatment of MASLD
10.1007/s11695-024-07178-5 · 2024 · External reference
Combination therapy of endoscopic gastric remodeling with GLP-1RA for the treatment of MASLD
10.1007/s11695-024-07178-5 · 2024 · External reference
